ABEONA THERAPEUTICS INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $42.4M | $32.9M |
| FY2022 | — | $26.8M | $14.2M |
| FY2023 | — | $14.8M | $14.5M |
| FY2024 | $13.0M | $44.0M | $23.4M |
| FY2025 | $7.8M | $159.2M | $78.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $42.4M | $32.9M |
| FY2022 | — | $26.8M | $14.2M |
| FY2023 | — | $14.8M | $14.5M |
| FY2024 | $13.0M | $44.0M | $23.4M |
| FY2025 | $7.8M | $159.2M | $78.4M |